| Year |
Citation |
Score |
| 2016 |
Weatherman RV. The role of selective estrogen receptor destabilizers (SERDs) in breast cancer therapy Drugs of the Future. 41: 361-366. DOI: 10.1358/Dof.2016.041.06.2482681 |
0.49 |
|
| 2012 |
Shearer KE, Rickert EL, Peterson AC, Weatherman RV. Dissecting rapid estrogen signaling with conjugates. Steroids. 77: 968-73. PMID 22417626 DOI: 10.1016/J.Steroids.2012.02.021 |
0.769 |
|
| 2012 |
Shah VP, Chegini HA, Vishneski SR, Weatherman RV, Blackmore PF, Dobrydneva Y. Tamoxifen promotes superoxide production in platelets by activation of PI3-kinase and NADPH oxidase pathways. Thrombosis Research. 129: 36-42. PMID 21875743 DOI: 10.1016/J.Thromres.2011.08.010 |
0.391 |
|
| 2010 |
Rickert EL, Oriana S, Hartman-Frey C, Long X, Webb TT, Nephew KP, Weatherman RV. Synthesis and characterization of fluorescent 4-hydroxytamoxifen conjugates with unique antiestrogenic properties. Bioconjugate Chemistry. 21: 903-10. PMID 20420372 DOI: 10.1021/Bc900461H |
0.794 |
|
| 2010 |
Weatherman R. Cancer Drug Discovery and Development-Hormone Therapy in Breast and Prostate Cancer. Edited by V. Craig Jordan and Barrington J. A. Furr. Chemmedchem. 5: 1153-1154. DOI: 10.1002/Cmdc.201000071 |
0.318 |
|
| 2008 |
Weatherman RV. Sensing estrogen's many pathways. Acs Chemical Biology. 3: 338-40. PMID 18570353 DOI: 10.1021/Cb800129Q |
0.507 |
|
| 2007 |
Dobrydneva Y, Weatherman RV, Trebley JP, Morrell MM, Fitzgerald MC, Fichandler CE, Chatterjie N, Blackmore PF. Tamoxifen stimulates calcium entry into human platelets. Journal of Cardiovascular Pharmacology. 50: 380-90. PMID 18049305 DOI: 10.1097/Fjc.0B013E31811Ec748 |
0.702 |
|
| 2007 |
Rickert EL, Trebley JP, Peterson AC, Morrell MM, Weatherman RV. Synthesis and characterization of bioactive tamoxifen-conjugated polymers. Biomacromolecules. 8: 3608-12. PMID 17929966 DOI: 10.1021/Bm070413T |
0.696 |
|
| 2007 |
Fan M, Rickert EL, Chen L, Aftab SA, Nephew KP, Weatherman RV. Characterization of molecular and structural determinants of selective estrogen receptor downregulators. Breast Cancer Research and Treatment. 103: 37-44. PMID 17033922 DOI: 10.1007/S10549-006-9353-2 |
0.784 |
|
| 2006 |
Trebley JP, Rickert EL, Reyes PT, Weatherman RV. Tamoxifen-based probes for the study of estrogen receptor-mediated transcription. Ernst Schering Research Foundation Workshop. 75-87. PMID 16709000 |
0.705 |
|
| 2006 |
Weatherman RV. Untangling the estrogen receptor web. Nature Chemical Biology. 2: 175-6. PMID 16547474 DOI: 10.1038/Nchembio0406-175 |
0.539 |
|
| 2004 |
Johnson MD, Zuo H, Lee KH, Trebley JP, Rae JM, Weatherman RV, Desta Z, Flockhart DA, Skaar TC. Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen. Breast Cancer Research and Treatment. 85: 151-9. PMID 15111773 DOI: 10.1023/B:Brea.0000025406.31193.E8 |
0.759 |
|
| 2003 |
Weatherman RV. Chemical approaches to studying transcription. Organic & Biomolecular Chemistry. 1: 3257-60. PMID 14584784 DOI: 10.1039/B307987B |
0.351 |
|
| 2002 |
Weatherman RV, Chang CY, Clegg NJ, Carroll DC, Day RN, Baxter JD, McDonnell DP, Scanlan TS, Schaufele F. Ligand-selective interactions of ER detected in living cells by fluorescence resonance energy transfer. Molecular Endocrinology (Baltimore, Md.). 16: 487-96. PMID 11875107 DOI: 10.1210/Mend.16.3.0813 |
0.761 |
|
| 2001 |
Weatherman RV, Carroll DC, Scanlan TS. Activity of a tamoxifen-raloxifene hybrid ligand for estrogen receptors at an AP-1 site. Bioorganic & Medicinal Chemistry Letters. 11: 3129-31. PMID 11720858 DOI: 10.1016/S0960-894X(01)00646-1 |
0.587 |
|
| 2001 |
Weatherman RV, Clegg NJ, Scanlan TS. Differential SERM activation of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites. Chemistry & Biology. 8: 427-36. PMID 11358690 DOI: 10.1016/S1074-5521(01)00025-4 |
0.78 |
|
| 2001 |
Weatherman RV, Scanlan TS. Unique protein determinants of the subtype-selective ligand responses of the estrogen receptors (ERalpha and ERbeta ) at AP-1 sites. The Journal of Biological Chemistry. 276: 3827-32. PMID 11060287 DOI: 10.1074/Jbc.M005414200 |
0.647 |
|
| 2000 |
Webb P, Nguyen P, Valentine C, Weatherman RV, Scanlan TS, Kushner PJ. An antiestrogen-responsive estrogen receptor-alpha mutant (D351Y) shows weak AF-2 activity in the presence of tamoxifen. The Journal of Biological Chemistry. 275: 37552-8. PMID 10986290 DOI: 10.1074/Jbc.M007435200 |
0.59 |
|
| 1999 |
Weatherman RV, Fletterick RJ, Scanlan TS. Nuclear-receptor ligands and ligand-binding domains. Annual Review of Biochemistry. 68: 559-81. PMID 10872460 DOI: 10.1146/annurev.biochem.68.1.559 |
0.597 |
|
| Show low-probability matches. |